School of Medicine
Showing 8,441-8,460 of 12,915 Results
-
Bianca Palushaj, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Bianca Palushaj is a board-certified, fellowship-trained neurologist with Stanford Health Care. She is also a Clinical Assistant Professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.
Dr. Palushaj specializes in movement disorders, including but not limited to Parkinson’s disease (PD) and atypical parkinsonian disorders, essential tremor, and dystonia. She has also developed a practice in diagnosing and treating disorders of gut-brain interaction (DGBI), which often occur in individuals with neurodegenerative disease.
She enjoys caring for the whole person and looks at how all parts of the body are connected. She considers how things like sleep, stress, diet, and daily habits can affect the microbiome, gut, brain, and overall well-being.
Dr. Palushaj’s research focuses on advancing our understanding and treatment of PD. She has special interest in the gut-brain connection in PD, including the role of the gut microbiome and inflammation in PD. She has also investigated how to measure non-motor PD symptoms, such as gastrointestinal dysfunction, using noninvasive, wearable technologies.
Dr. Palushaj has published her findings in peer-reviewed journals including Journal of Neurology, NeuroImage, and Cell Reports Methods. She has also written chapters for integrative medicine books on PD and Alzheimer’s disease.
Dr. Palushaj has presented at international, national, and regional conferences, including the Alzheimer’s Disease and Parkinson’s Disease (AD/PD™) Conference and the Parkinson Study Group Annual Meeting. She has also spoken about her research to several PD support groups across Northern California, including PD Active and Parkinson’s Support Group of Sonoma County.
Dr. Palushaj is a member of the American Academy of Neurology, the American Neurogastroenterology and Motility Society, and the International Parkinson and Movement Disorder Society. She is also a member of Women in Neurology and Women in Medicine. -
Carolyn K. Pan, MD
Clinical Professor, Ophthalmology
BioDr. Pan is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon. She focuses on retinal vascular diseases, macular degeneration, and surgical repair of retinal detachments, macular pathology, and complications from cataract surgery. She has co-authored peer-reviewed articles on topics ranging from optical coherence tomography imaging to embryonic stem cells for macular degeneration.
In addition to her clinical practice, she is dedicated to the education and training of medical students, residents, and fellows. As recognition of her efforts, she received the Faculty Teaching Award in 2016 from the Byers Eye Institute at Stanford University and was the recipient of the national Women in Ophthalmology Educator Award in 2024. Within the department, she was the Associate Residency Program Director from 2020 to 2023, and currently serves as the Residency Program Director. Her educational efforts also extend beyond the department - since 2016, she has served on the annual meeting planning committee for the American Academy of Ophthalmology and is currently Associate Secretary of the Annual Meeting and Chair of the Special Projects Committee.
Dr. Pan's clinical practice is mainly based at Santa Clara Valley Medical Center, Stanford's affiliate county hospital, where she is chief of the retina service. -
Jennifer Yi-Jiun Pan
Clinical Assistant Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioMy research interests thus far have focused on immunology, GI cancers, and improving quality of care for patients. I am passionate about understanding the different genetic and lifestyle factors that are involved in GI cancers and other colonic pathology, as well as improving systems of care to better manage the health and improve the outcomes of patients with these diseases. Towards that end, I have been involved in research in Lynch syndrome in order to bridge the gap between our current understanding of cancer risk in this high-risk population and the creation and implementation of guidelines worldwide. I also had the opportunity to work with collaborators in the International Mismatch Repair Consortium at the Department of Colorectal Medicine and Genetics with the Royal Melbourne Hospital in Australia where I saw firsthand the global efforts in the fight against colorectal cancer. In my current role as a staff gastroenterologist at the VA Palo Alto, I oversee the colorectal cancer prevention program. My goal is to continue to be part of and contribute to collaborative clinical and research efforts in order to provide the best care for our patients.
Professional Education:
- Fellowship: Stanford University--Gastroenterology (2016)
- MS: Stanford University--Epidemiology and Clinical Research (2016)
- Residency: Yale-New Haven Hospital--Internal Medicine (2013)
- MD: University of Texas Southwestern Medical Center (2010)
- AB: Harvard College--Biochemical Sciences (2006)
Honors and Awards:
- American College of Gastroenterology North American International GI Training Grant (2016)
Professional Memberships:
- American Gastroenterological Association
-- Delegate, AGA Trainee and Early Career GI Committee (2016-2018)
-- Regional Planner, AGA Regional Practice Skills Workshop – California (2016-2017)
- Northern California Society for Clinical Gastroenterology2014 – Present
-- Education and Trainee Committee (2021-Present)
-- Communications Committee (2021-Present)
Selected NCBI Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/jennifer.pan.1/bibliography/public/ -
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
Dr. Pan has more than eighty publications and presented many abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, Nature Nanotechnology, Frontier Endocrinology, JCO Oncology Practice, Journal of Hematology and Oncology, British Journal of Cancer Reports, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), Chinese Society Of Clinical Oncology (CSCO), Connective Tissue Oncology Society (CTOS) and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association for Cancer Research, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
John Christopher (J.C.) Panagides
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyBioCurrent Integrated Interventional and Diagnostic Radiology (IR/DR) Resident at Stanford Medicine and recent graduate of Harvard Medical School (Class of 2023) with deep interests in emerging applications of interventional and diagnostic radiology, minimally invasive procedures, and biomedical engineering. Extensive experience in biomedical project design and clinical research in predictive analytics, radiology practice management, and population health outcomes.
